Abstract
We have used the Hepatitis B Virus DNA genome as a probe to identify genes clonally mutated in vivo, in human liver cancers. In a tumor, HBV-DNA was found to be integrated into the gene encoding Sarco/Endoplasmic Reticulum Calcium ATPase (SERCA), which pumps calcium, an important intracellular messenger for cell viability and growth, from the cytosol to the endoplasmic reticulum. The HBV X gene promoter cis-activates chimeric HBV X/SERCA1 transcripts, with splicing of SERCA1 exon 11, encoding C-terminally truncated SERCA1 proteins. Two chimeric HBV X/SERCA1 proteins accumulate in the tumor and form dimers. In vitro analyses have demonstrated that these proteins localize to the ER, determine its calcium depletion and induce cell death. We have also shown that these biological effects are related to expression of the SERCA, rather than of the viral moiety. This report involves for the first time the expression of mutated SERCA proteins in vivo in a tumor cell proliferation and in vitro in the control of cell viability.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bayle D, Weeks D, Hallen S, Melchers K, Bamberg K and Sachs G . 1997 J Recept Signal Transduct Res 17: 29–56
Benn J and Schneider R . 1994 Proc Natl Acad Sci USA 91: 10350–10354
Benn J and Schneider R . 1995 Proc Natl Acad Sci USA 92: 11215–11219
Berasain C, Patil D, Perera E, Huang S, Mouly H and Bréchot C . 1998 Oncogene 16: 1277–1288
Berridge MJ, Bootman MD and Lipp P . 1998 Nature 395: 645–648
Brostrom CO and Brostrom MA . 1990 Annu Rev Physiol 52: 577–590
Buendia MA . 1992 Adv Cancer Res 59: 167–226
Camacho P and Lechleiter JD . 1993 Science 260: 226–229
Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS et al. 1997 New Engl J Med 336: 1855–1859
Cheong JH, Yi M, Lin Y and Murakami S . 1995 EMBO J 14: 143–150
Chirillo P, Falco M, Puri PL, Artini M, Balsano C, Levrero M and Natoli G . 1996 J Virol 70: 641–644
Chirillo P, Pagano S, Natoli G, Puri P, Burgio V, Balsano C and Levrero M . 1997 Proc Natl Acad Sci USA 94: 8162–8167
Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S, Pinkert CA, Brinster RL and Palmiter RD . 1989 Cell 59: 1145–1156
Chung DC, Brown SB, Graeme-Cook F, Tillotson LG, Warshaw AL, Jensen RT and Arnold A . 1998 Cancer Res 58: 3706–3711
Church GM and Gilbert W . 1984 Proc Natl Acad Sci USA 81: 1991–1995
Dejean A, Bougueleret L, Grzeschik KH and Tiollais P . 1986 Nature 322: 70–72
Dolmetsch RE, Lewis RS, Goodnow CC and Healy JI . 1997 Nature 386: 855–858
Dorjsuren D, Lin Y, Wei W, Yamashita T, Nomura T, Hayashi N and Murakami S . 1998 Mol Cell Biol 18: 7546–7555
Falson P, Menguy T, Corre F, Bouneau L, de Gracia AG, Soulie S, Centeno F, Moller JV, Champeil P and le Maire, M . 1997 J Biol Chem 272: 17258–17262
Fourel G, Couturier J, Wei Y, Apiou F, Tiollais P and Buendia MA . 1994 EMBO J 13: 2526–2534
Garcia M, De Thé H, Tiollais P, Samarut J and Dejean A . 1993 Cell Biol 90: 89–93
Graef E, Caselmann W, Wells J and Koshy R . 1994 Oncogene 9: 81–87
Grynkiewicz G, Poenie M and Tsien RY . 1985 J Biol Chem 260: 3440–3450
Guerini D, Garcia-Martin E, Zecca A, Guidi F and Carafoli E . 1998 Acta Physiol Scand Suppl 643: 265–273
Heilmann C, Spamer C and Gerok W . 1985 J Biol Chem 260: 788–794
Hildt E, Hofschneider P and Urban S . 1996 Virology 7: 333–347
Kaufman RJ . 1999 Genes Dev 13: 1211–1233
Kekulé AS . 1994 Primary liver cancer Etiological and progression factors, Vol 13: Bréchot C ed CRC Press London
Kim C, Koike K, Saito I, Miyamura T and Jay G . 1991 Nature 351: 317–320
Kohn E and Liotta L . 1995 Cancer Res 55: 1856–1862
Koike K . 1998 Hepatitis B virus molecular mechanisms in disease and novel strategies for therapy, Vol 3: Koshy R and Caselmann WH eds Imperial College Press London pp 133–160
Koike K, Moriya H, Yotsuyanagi H, Iino S and Kurokawa K . 1994 J Clin Invest 94: 44–49
Lee TH, Elledge SJ and Butel JS . 1995 J Virol 69: 1107–1114
Lee YH and Yun Y . 1998 J Biol Chem 273: 25510–25515
Lin MH and Lo SC . 1989 Biochem Biophys Res Commun 164: 14–21
Ma TS, Mann DL, Lee JH and Gallinghouse GJ . 1999 Cell Calcium 26: 25–36
MacLennan DH, Rice WJ and Green NM . 1997 J Biol Chem 272: 28815–28818
MacLennan DH, Rice WJ, Odermatt A and Green NM . 1998 Acta Physiol Scand Suppl 643: 55–67
Martonosi AN . 1996 Biochim Biophys Acta 1275: 111–117
Minami M, Poussin K, Bréchot C and Paterlini P . 1995 Genomics 29: 403–408
Morgan AJ and Jacob R . 1998 J Physiol Lond 513: 83–101
Nicotera P and Orrenius S . 1998 Cell Calcium 23: 173–180
Ottesen AM, Kirchhoff M, De-Meyts ER, Maahr J, Gerdes T, Rose H, Lundsteen C, Petersen PM, Philip J and Skakkebaek NE . 1997 Genes Chromosomes Cancer 20: 412–418
Pahl HL and Baeuerle PA . 1997 Trends Biochem Sci 22: 63–67
Paterlini P and Bréchot C . 1994 Primary liver cancer Etiological and progression factors, Vol 12 Bréchot C ed CRC Press London pp 167–190
Paterlini P, Gerken G, Khemeny D, Franco D, D'Errico A, Grigioni W, Wands J, Kew M, Pisi E, Tiollais P and Bréchot C . 1990 Viral hepatitis and liver disease Hollinger FB, Lemon SM and Margolis HS eds. Williams and Wilkins Baltimore pp 556–559
Peacocke M and Christiano AM . 1999 Nat Genet 21: 252–253
Petit PX, Lecoeur H, Zorn E, Dauguet C, Mignotte B and Gougeon ML . 1995 J Cell Biol 130: 157–167
Pineau P, Marchio A, Terris B, Mattei MG, Tu ZX, Tiollais P and Dejean A . 1996 J Virol 70: 7280–7284
Pirc-Danoewinata H, Bull JP, Okamoto I, Karner J, Breiteneder S, Liebhardt A, Budinsky A and Marosi C . 1996 Wien Klin Wochenschr 108: 752–758
Pozzan T, Rizzuto R, Volpe P and Meldolesi J . 1994 Physiol Rev 74: 595–635
Raney AK and McLachlan A . 1991 Molecular biology of Hepatitis B Virus McLachlan A ed CRC Press pp 1–26
Rice WJ and MacLennan DH . 1996 J Biol Chem 271: 31412–31419
Sakuntabhai A, Ruiz-Perez V, Carter S, Jacobsen N, Burge S, Monk S, Smith M, Munro CS, O'Donovan M, Craddock N, Kucherlapati R, Rees JL, Owen M, Lathrop GM, Monaco AP, Strachan T and Hovnanian A . 1999 Nat Genet 21: 271–277
Sirma H, Giannini C, Poussin K, Paterlini P, Kremsdorf D and Bréchot C . 1999 Oncogene 18: 4848–4859
Sirma H, Weil R, Rosmorduc O, Urban S, Israel A, Kremsdorf D and Bréchot C . 1998 Oncogene 16: 2051–2063
Sitterlin D, Lee TH, Prigent S, Tiollais P, Butel JS and Transy C . 1997 J Virol 71: 6194–6199
Slagle B, Lee T, Medina D, Finegold M and Butel J . 1996 Mol Carcinog 15: 261–269
Soulié S, Moller JV, Falson P and le Maire M . 1996 Anal Biochem 236: 363–364
Sun BS, Zhu X, Clayton MM, Pan J and Feitelson MA . 1998 Hepatology 27: 228–239
Terradillos O, Billet O, Renard C, Levy R, Molina T, Briand P and Buendia M . 1997 Oncogene 14: 395–404
Terradillos O, Pollicino T, Lecoeur H, Tripodi M, Gougeon ML, Tiollais P and Buendia MA . 1998 Oncogene 17: 2115–2123
Truant R, Antunovic J, Greenblatt J, Prives C and Cromlish J . 1995 J Virol 69: 1851–1859
Wang J, Chenivesse X, Henglein B and Bréchot C . 1990 Nature 343: 555–557
Wang X, Forrester K, Yeh H, Feitelson M, Gu J and Harris C . 1994a Proc Natl Acad Sci USA 91: 2230–2234
Wang X, Gibson M, Vermeulen W, Yeh H, Forester K, Stûrzbecher H, Hoeijmekers J and Harris C . 1995 Cancer Res 55: 6012–6016
Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR and Harris CC . 1994b Proc Natl Acad Sci USA 91: 2230–2234
Weil R, Sirma H, Giannini C, Kremsdorf D, Bessia C, Dargemont C, Bréchot C and Israel A . 1999 Mol Cell Biol 19: 6345–6354
Williams JS and Andrisani OM . 1995 Proc Natl Acad Sci USA 92: 3819–3823
Wu KD, Lee WS, Wey J, Bungard D and Lytton J . 1995 Am J Physiol 269: C775–C784
Zhang Y, Fujii J, Phillips M, Chen H-S, Karpati G, Yee W-C, Schrank B, Cornblath D, Bobylan K and MacLennan D . 1995 Genomics 30: 415–424
Acknowledgements
We thank P Champeil for critical reading of the paper and most helpful discussion. This work was supported by grants from INSERM, LNC no 8981 and ARC no 9327 (France). M Chami, D Gozuacik and K Saigo are recipient of fellowships from LNC (France), TUBITAK (Turkey) and FRM (France), respectively.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chami, M., Gozuacik, D., Saigo, K. et al. Hepatitis B virus-related insertional mutagenesis implicates SERCA1 gene in the control of apoptosis. Oncogene 19, 2877–2886 (2000). https://doi.org/10.1038/sj.onc.1203605
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203605
Keywords
This article is cited by
-
DeepHBV: a deep learning model to predict hepatitis B virus (HBV) integration sites
BMC Ecology and Evolution (2021)
-
Calcium signaling in hepatitis B virus infection and its potential as a therapeutic target
Cell Communication and Signaling (2021)
-
Hepatitis B virus X gene and hepatocarcinogenesis
Journal of Gastroenterology (2011)
-
Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis
Oncogene (2008)